Iran-Cuba COVID-19 vaccine enters phase three clinical trials
(Payvand Iran News)

Iran started on Monday the third phase of the human trial of the Soberana-02 coronavirus vaccine, jointly developed with Cuba. Manufactured by Cuba`s Finlay Vaccine Institute and Pasteur Institute of Iran, the vaccine is a conjugate vaccine with two injectable doses. It consists of the receptor-binding domain of the SARS-CoV-2 spike protein conjugated chemically to tetanus toxoid, IRIB reported.